BioCentury
ARTICLE | Finance

Swiss miss

Switzerland's Addex wants a U.S. listing to boost visibility with investors

February 11, 2013 8:00 AM UTC

Plans by Addex Therapeutics Ltd. (SIX:ADXN) to add a U.S. listing suggest the Swiss stock exchange may not be the safe haven it once was for regional biotechs. Addex will seek the listing this half to boost its trading liquidity.

The company's announcement came as part of a restructuring plan that involves suspending all discovery work while it focuses on developing three programs that are in or near the clinic for rare disease indications...